IBDEI0CX ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5923,1,3,0)
 ;;=3^Acute Lymphangitis of Perineum
 ;;^UTILITY(U,$J,358.3,5923,1,4,0)
 ;;=4^L03.325
 ;;^UTILITY(U,$J,358.3,5923,2)
 ;;=^5009059
 ;;^UTILITY(U,$J,358.3,5924,0)
 ;;=L03.326^^30^385^29
 ;;^UTILITY(U,$J,358.3,5924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5924,1,3,0)
 ;;=3^Acute Lymphangitis of Umbilicus
 ;;^UTILITY(U,$J,358.3,5924,1,4,0)
 ;;=4^L03.326
 ;;^UTILITY(U,$J,358.3,5924,2)
 ;;=^5009060
 ;;^UTILITY(U,$J,358.3,5925,0)
 ;;=L03.329^^30^385^28
 ;;^UTILITY(U,$J,358.3,5925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5925,1,3,0)
 ;;=3^Acute Lymphangitis of Trunk,Unspec
 ;;^UTILITY(U,$J,358.3,5925,1,4,0)
 ;;=4^L03.329
 ;;^UTILITY(U,$J,358.3,5925,2)
 ;;=^5009062
 ;;^UTILITY(U,$J,358.3,5926,0)
 ;;=L08.9^^30^385^167
 ;;^UTILITY(U,$J,358.3,5926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5926,1,3,0)
 ;;=3^Local Infection of Skin/Subcutaneous Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,5926,1,4,0)
 ;;=4^L08.9
 ;;^UTILITY(U,$J,358.3,5926,2)
 ;;=^5009082
 ;;^UTILITY(U,$J,358.3,5927,0)
 ;;=L11.0^^30^385^9
 ;;^UTILITY(U,$J,358.3,5927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5927,1,3,0)
 ;;=3^Acquired Keratosis Follicularis
 ;;^UTILITY(U,$J,358.3,5927,1,4,0)
 ;;=4^L11.0
 ;;^UTILITY(U,$J,358.3,5927,2)
 ;;=^5009091
 ;;^UTILITY(U,$J,358.3,5928,0)
 ;;=L20.0^^30^385^90
 ;;^UTILITY(U,$J,358.3,5928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5928,1,3,0)
 ;;=3^Besnier's Prurigo
 ;;^UTILITY(U,$J,358.3,5928,1,4,0)
 ;;=4^L20.0
 ;;^UTILITY(U,$J,358.3,5928,2)
 ;;=^5009107
 ;;^UTILITY(U,$J,358.3,5929,0)
 ;;=L20.81^^30^385^87
 ;;^UTILITY(U,$J,358.3,5929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5929,1,3,0)
 ;;=3^Atopic Neurodermatitis
 ;;^UTILITY(U,$J,358.3,5929,1,4,0)
 ;;=4^L20.81
 ;;^UTILITY(U,$J,358.3,5929,2)
 ;;=^5009108
 ;;^UTILITY(U,$J,358.3,5930,0)
 ;;=L20.82^^30^385^150
 ;;^UTILITY(U,$J,358.3,5930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5930,1,3,0)
 ;;=3^Flexural Eczema
 ;;^UTILITY(U,$J,358.3,5930,1,4,0)
 ;;=4^L20.82
 ;;^UTILITY(U,$J,358.3,5930,2)
 ;;=^5009109
 ;;^UTILITY(U,$J,358.3,5931,0)
 ;;=L20.84^^30^385^162
 ;;^UTILITY(U,$J,358.3,5931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5931,1,3,0)
 ;;=3^Intrinsic Eczema
 ;;^UTILITY(U,$J,358.3,5931,1,4,0)
 ;;=4^L20.84
 ;;^UTILITY(U,$J,358.3,5931,2)
 ;;=^5009111
 ;;^UTILITY(U,$J,358.3,5932,0)
 ;;=L20.89^^30^385^85
 ;;^UTILITY(U,$J,358.3,5932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5932,1,3,0)
 ;;=3^Atopic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,5932,1,4,0)
 ;;=4^L20.89
 ;;^UTILITY(U,$J,358.3,5932,2)
 ;;=^5009112
 ;;^UTILITY(U,$J,358.3,5933,0)
 ;;=L20.9^^30^385^86
 ;;^UTILITY(U,$J,358.3,5933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5933,1,3,0)
 ;;=3^Atopic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,5933,1,4,0)
 ;;=4^L20.9
 ;;^UTILITY(U,$J,358.3,5933,2)
 ;;=^5009113
 ;;^UTILITY(U,$J,358.3,5934,0)
 ;;=L21.8^^30^385^262
 ;;^UTILITY(U,$J,358.3,5934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5934,1,3,0)
 ;;=3^Seborrheic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,5934,1,4,0)
 ;;=4^L21.8
 ;;^UTILITY(U,$J,358.3,5934,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,5935,0)
 ;;=L21.9^^30^385^263
 ;;^UTILITY(U,$J,358.3,5935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5935,1,3,0)
 ;;=3^Seborrheic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,5935,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,5935,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,5936,0)
 ;;=L23.7^^30^385^30
 ;;^UTILITY(U,$J,358.3,5936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5936,1,3,0)
 ;;=3^Allergic Contact Dermatitis d/t Plants
 ;;^UTILITY(U,$J,358.3,5936,1,4,0)
 ;;=4^L23.7
